تحميل...
Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST
OBJECTIVE: To explore the role of surgery of residual disease following a period of therapy with imatinib mesylate in advanced gastrointestinal stromal tumors (GIST). METHODS: From January 2001 to June 2005, 159 patients with advanced/metastatic GIST were treated with imatinib mesylate at a single i...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2007
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1877023/ https://ncbi.nlm.nih.gov/pubmed/17435538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.sla.0000242710.36384.1b |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|